Results 1 to 10 of about 34,150 (225)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma

Diagnostics, 2022
Malignant pleural mesothelioma is a rare cancer characterized by a very poor prognosis. Exposure to asbestos is the leading cause of malignant pleural mesothelioma.
Jacopo Moro, Simona Sobrero, Carlotta Francesca Cartia, Simona Ceraolo, Roberta Rapanà, Federico Vaisitti, Stefano Ganio, Federica Mellone, Stefano Rudella, Federico Scopis, Danilo La Paglia, Carola Crystel Cacciatore, Enrico Ruffini, Francesco Leo   +13 more
doaj   +3 more sources

Risk factors, prognostic factors, and nomograms for distant metastasis in patients with malignant pleural mesothelioma: A population-based retrospective study [PDF]

Journal of International Medical Research
Objectives Malignant pleural mesothelioma is a rare and aggressive thoracic tumor with a poor prognosis, wherein distant metastasis is associated with the lowest survival rates.
Quzhe Lu, Chao Liu, Meixiang Xu, Zhi Hu, Hui Yin, Jie Yang   +5 more
doaj   +2 more sources

The usefulness of full-thickness biopsy during semi-rigid pleuroscopy for differentiating between malignant pleural mesothelioma and non-specific pleurisy [PDF]

BMC Pulmonary Medicine
Background Malignant pleural mesothelioma is a rare disease with a poor prognosis; distinguishing it from non-specific pleurisy is essential for determining an appropriate treatment strategy. We aimed to evaluate the diagnostic utility and safety of full-
Takahiro Ueda, Toshiyuki Nakai, Sayaka Tanaka, Hiroaki Nagamine, Atsushi Miyamoto, Misako Nishimura, Yoshiya Matsumoto, Kanako Sato, Kazuhiro Yamada, Tetsuya Watanabe, Kazuhisa Asai, Yuji Matsumoto, Yu Mikami, Tomoya Kawaguchi   +13 more
doaj   +2 more sources

Malignant pleural mesothelioma [PDF]

Lung India, 2009
Malignant mesothelioma is one of the rare tumors of pleura. One such case in a 57-year-old male, who presented with hemorrhagic pleural effusion and had no history of asbestos exposure, is reported here. The rarity, unusual presentation, and implications
Rao Sukhesh
doaj   +7 more sources

Multimodal treatment for resectable epithelial type malignant pleural mesothelioma [PDF]

World Journal of Surgical Oncology, 2004
Background Malignant pleural mesothelioma is a rare malignancy. The outcome remains poor despite complete surgical resection. Patients and methods Eleven patients with histologicaly proven epithelial type malignant pleural mesothelioma undergoing ...
Fukuyama Yasuro, Ushijima Chie, Okamoto Tatsuro, Yamaguchi Masafumi, Yoshino Ichiro, Ichinose Yukito, Maehara Yoshihiko   +6 more
doaj   +3 more sources

Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly? [PDF]

Cancer Control
Background: Malignant pleural mesothelioma is the most common primary tumor of the pleura. The unique growth pattern of malignant pleural mesothelioma makes it difficult to apply the Response Evaluation Criteria for Solid Tumors (RECIST).
Carmine Picone, Annamaria Porto, Roberta Fusco, Vincenza Granata, Maria Chiara Brunese, Agnese Montanino, Giovanna Esposito, Raffaele Costanzo, Anna Manzo, Vincenzo Sforza, Claudia Sandomenico, Giuliano Palumbo, Edoardo Mercadante, Alessandro Ottaiano, Gianfranco Vallone, Ferdinando Caranci, Raffaella Mormile, Alessandro Morabito, Antonella Petrillo   +18 more
doaj   +2 more sources

Malignant pleural mesothelioma [PDF]

Annals of Oncology, 1998
The incidence of malignant pleural mesothelioma (MPM) has risen for some decades and is expected to peak between 2010 and 2020. Up to now, no single treatment has been proven to be effective and death usually occurs within about 12-17 months after diagnosis. Perhaps because of this poor prognosis, early screening has incited little interest.
P, Baas, H, Schouwink, F A, Zoetmulder
openaire   +4 more sources

The role of CD24 as a potential biomarker for malignant pleural mesothelioma

Egyptian Journal of Chest Disease and Tuberculosis, 2023
Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa, Ahmed Mamdooh Ghoname, Dalia Abd El-Kareem Ateya, Hamed A H Abdallah, Salwa Hassan Ahmed   +4 more
doaj   +1 more source

Malignant pleural mesothelioma [PDF]

American Journal of Health-System Pharmacy, 2012
PURPOSE The etiology, diagnosis, staging, and management of malignant pleural mesothelioma (MPM) are reviewed, with an emphasis on clinical trials of newer approaches to first-line, second-line, and adjuvant chemotherapy.In the past decade, more effective chemotherapy regimens have been developed for patients with MPM, a rapidly progressing disease ...
Sheree E, Chen, Makala B, Pace
openaire   +4 more sources

Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma

Biomedicines, 2022
Malignant pleural mesothelioma is an aggressive malignancy with poor prognosis. Unilateral pleural effusion is frequently the initial clinical sign requiring therapeutic thoracentesis, which also offers a diagnostic opportunity.
Lorenzo Zallocco, Roberto Silvestri, Federica Ciregia, Alessandra Bonotti, Riccardo Marino, Rudy Foddis, Antonio Lucacchini, Laura Giusti, Maria Rosa Mazzoni   +8 more
doaj   +1 more source